Pharmaceutical Technology is using cookies

We use them to give you the best experience. If you continue using our website, we'll assume that you are happy to receive all cookies on this website.

ContinueLearn More X

The UK’s Cancer Drugs Fund: a model for access and reimbursement?

In 2016, NHS England established the Cancer Drugs Fund to allow UK patients fast access to particularly innovative drugs where the clinical evidence is not sufficiently mature; this is the first and, believed to be, only managed access scheme globally. CDF national operational lead Nina Pinwill explains the process and the benefits it brings to patients, as well as picking out a few examples of particularly innovative drugs that have been approved as a result of this funding option.


Go Top